AN2 Therapeutics $100 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
AVITA Medical at-the-market offering
The stock is listed on the Nasdaq Global Market
InflaRx follow-on offering
The shares are listed on the Nasdaq Global Market
Medtronic Global Holdings $2 billion notes offering
The investment-grade offering comprises two tranches of notes
Intercept Pharmaceuticals $100 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
Kenvue $7.75 billion senior notes offering
The investment-grade offering comprises eight tranches of notes
Cigna $1.5 billion senior notes offering
The senior notes are due 2026 and 2033
Revolution Medicines $345 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
Ardelyx $150 million at-the-market offering
The shares are listed on the Nasdaq Global Market
European Biotech Acquisition $220 million combination with Oculis
We advised European Biotech Acquisition on its de-SPAC transaction